
Good News: Genetic Savings & Clone Closes Up Shop
This is a huge, muted victory for biomedical ethics, a victory that was won in the free market (an added bonus, though not essential in these cases).
An exerpt:
"Genetic Savings and Clone, a biotechnology company that sold cloned pets, sent letters to its customers last month informing them it will close at the end of the year because of little demand for costly cloned cats. The company had recently reduced the price from $50,000 to $32,000. The company also failed in its attempts to clone pet dogs.
"The letters said the Sausalito company was not accepting new orders for clones because it was ‘unable to develop the technology to the point that cloning pets is commercially viable.’"
This is where I part from a generally libertarian ethos. The inevitabilities of GS&C‘s work were horrifying to contemplate. I’m glad it’s done, for it provides government more time to weigh the issue. And government must weigh this issue. Medical… Read More